HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Arunachalam, B. Articles by Cresswell, P. Search for Related Content PubMed PubMed Citation Articles by Arunachalam, B. Articles by Cresswell, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB SODIUM LAURYL SULFATE

Intracellular Formation and Cell Surface Expression of a Complex of an Intact Lysosomal Protein and MHC Class II Molecules¹

Balasubramanian Arunachalam^*, Mary Pan and Peter Cresswell^2,

^* Department of Surgery and Section of Immunobiology, Yale University School of Medicine, and Howard Hughes Medical Institute, Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06510

The generation of invariant chain-free MHC class II molecules and their association with endocytically generated peptides are thought to occur in specialized lysosome-like compartments called MIICs (MHC class II compartments). A number of in vitro studies have shown that large denatured proteins can bind to class II molecules, and that class II association can protect the bound segment of protein from proteolytic degradation. In this work, we present what we believe is the first example of an intact endogenous protein (IP30) binding in an allele-dependent fashion to class II molecules in vivo. IP30 is an IFN--inducible 35-kDa glycoprotein that localizes in MIICs. In this study, we show that intact IP30 binds to certain HLA-DR alleles via an N-terminal prosequence. The association takes place in the endocytic pathway following removal of invariant chain from class II molecules and before their cell surface expression. We also show that DR-IP30 complexes are SDS stable. The potential precursor-product relationship between DR-IP30 complexes and the DR-peptide complex is discussed.

This article has been cited by other articles:

				M. Maric, I. Barjaktarevic, B. Bogunovic, M. Stojakovic, C. Maric, and S. Vukmanovic Cutting Edge: Developmental Up-Regulation of IFN-{gamma}-Inducible Lysosomal Thiol Reductase Expression Leads to Reduced T Cell Sensitivity and Less Severe Autoimmunity J. Immunol., January 15, 2009; 182(2): 746 - 750. [Abstract] [Full Text] [PDF]

				B. Bogunovic, M. Stojakovic, L. Chen, and M. Maric An Unexpected Functional Link between Lysosomal Thiol Reductase and Mitochondrial Manganese Superoxide Dismutase J. Biol. Chem., April 4, 2008; 283(14): 8855 - 8862. [Abstract] [Full Text] [PDF]

				K. T. Hastings, R. L. Lackman, and P. Cresswell Functional Requirements for the Lysosomal Thiol Reductase GILT in MHC Class II-Restricted Antigen Processing J. Immunol., December 15, 2006; 177(12): 8569 - 8577. [Abstract] [Full Text] [PDF]

				I. Barjaktarevic, A. Rahman, S. Radoja, B. Bogunovic, A. Vollmer, S. Vukmanovic, and M. Maric Inhibitory Role of IFN-{gamma}-Inducible Lysosomal Thiol Reductase in T Cell Activation J. Immunol., October 1, 2006; 177(7): 4369 - 4375. [Abstract] [Full Text] [PDF]

				R. L. Lackman and P. Cresswell Exposure of the Promonocytic Cell Line THP-1 to Escherichia coli Induces IFN-{gamma}-Inducible Lysosomal Thiol Reductase Expression by Inflammatory Cytokines J. Immunol., October 1, 2006; 177(7): 4833 - 4840. [Abstract] [Full Text] [PDF]

				R. D. Mason, M. I. Bowmer, C. M. Howley, and M. D. Grant Cross-Reactive Cytotoxic T Lymphocytes against Human Immunodeficiency Virus Type 1 Protease and Gamma Interferon-Inducible Protein 30 J. Virol., May 1, 2005; 79(9): 5529 - 5536. [Abstract] [Full Text] [PDF]

				Y. Kluger, D. P. Tuck, J. T. Chang, Y. Nakayama, R. Poddar, N. Kohya, Z. Lian, A. B. Nasr, H. R. Halaban, D. S. Krause, et al. Lineage specificity of gene expression patterns PNAS, April 27, 2004; 101(17): 6508 - 6513. [Abstract] [Full Text] [PDF]

				J. A. Shumilla, V. Lacaille, T. M. C. Hornell, J. Huang, S. Narasimhan, D. A. Relman, and E. D. Mellins Bordetella pertussis Infection of Primary Human Monocytes Alters HLA-DR Expression Infect. Immun., March 1, 2004; 72(3): 1450 - 1462. [Abstract] [Full Text] [PDF]

				I. Potolicchio, L. Santambrogio, and J. L. Strominger Molecular Interaction and Enzymatic Activity of Macrophage Migration Inhibitory Factor with Immunorelevant Peptides J. Biol. Chem., August 15, 2003; 278(33): 30889 - 30895. [Abstract] [Full Text] [PDF]

				U. T. Phan, R. L. Lackman, and P. Cresswell Role of the C-terminal propeptide in the activity and maturation of gamma -interferon-inducible lysosomal thiol reductase (GILT) PNAS, September 17, 2002; 99(19): 12298 - 12303. [Abstract] [Full Text] [PDF]

				B. Arunachalam, U. T. Phan, H. J. Geuze, and P. Cresswell Enzymatic reduction of disulfide bonds in lysosomes: Characterization of a Gamma-interferon-inducible lysosomal thiol reductase (GILT) PNAS, January 18, 2000; 97(2): 745 - 750. [Abstract] [Full Text] [PDF]

				G. Zhong, T. Fan, and L. Liu Chlamydia Inhibits Interferon {gamma}-inducible Major Histocompatibility Complex Class II Expression by Degradation of Upstream Stimulatory Factor 1 J. Exp. Med., June 21, 1999; 189(12): 1931 - 1938. [Abstract] [Full Text] [PDF]

				U. T. Phan, B. Arunachalam, and P. Cresswell Gamma-Interferon-inducible Lysosomal Thiol Reductase (GILT). MATURATION, ACTIVITY, AND MECHANISM OF ACTION J. Biol. Chem., August 18, 2000; 275(34): 25907 - 25914. [Abstract] [Full Text] [PDF]

				K. Honey, M. Duff, C. Beers, W. H. Brissette, E. A. Elliott, C. Peters, M. Maric, P. Cresswell, and A. Rudensky Cathepsin S Regulates the Expression of Cathepsin L and the Turnover of gamma -Interferon-inducible Lysosomal Thiol Reductase in B Lymphocytes J. Biol. Chem., June 15, 2001; 276(25): 22573 - 22578. [Abstract] [Full Text] [PDF]